1. P163 The impact of the COVID-19 pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease in The Netherlands. (27th May 2021) Authors: Paulides, E; Pasma, A; Erler, N S; van Eijk, R L A; de Vries, A C; van der Woude, C J Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P362 Faecal calprotectin is an early predictor of endoscopic response and histological remission after the start of vedolizumab. (25th January 2019) Authors: Pauwels, R W M; de Vries, A C; Goet, J C; Erler, N S; van der Woude, C J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P414 Ustekinumab endoscopic response at Week 16 is associated with early normalisation of faecal calprotectin after induction. (25th January 2019) Authors: Pauwels, R W M; de Vries, A C; Goet, J C; Erler, N S; van der Woude, C J Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P697 Thiopurines vs. anti-TNFa for the prevention of postoperative recurrence in Crohn's disease—a meta-analysis. (16th January 2018) Authors: Beelen, E M J; Oldenburg, B; van der Meulen-de Jong, A E; Ponsioen, C I J; Dijkstra, G; Pierik, M J; Hoentjen, F; de Boer, N K H; Erler, N S; van der Woude, C J; de Vries, A C Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗